assess effectiveness of a , compared with usual care, to assess The goal of this study is to learn if a modified clinical program can improve adherence to guideline recommendations for prevention of venous thromboembolism in ambulatory patients with cancer. The main question\[s\] it aims to answer are: Does the modified program improve number of ambulatory oncology patients starting systemic treatment getting VTE risk-assessment? Does the modified program improve the number of patients receiving appropriate preventative anticoagulation? Researchers will compare to usual care (no clinical program). Participant clinicians will be asked to * receive education about VTE prevention recommendations * carry out risk assessment, anticoagulation discussions, and document the results Participant patients will receive care from clinicians participating in the study as part of their cancer care.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
25
Revised Vermont Model clinical program, including standardized education and training for oncology care team, clinical decision support and revised workflow for VTE risk assessment and thromboprophylaxis.
Vermont Health
Burlington, Vermont, United States
Documented VTE risk assessment
Proportion of new patients who have documented VTE risk assessment
Time frame: 30 days after new patient appointment
Appropriate thromboprophylaxis
Proportion of identified high-risk patients with prescription for thromboprophylaxis and low-risk patients without thromboprophylaxis
Time frame: 30 days after new patient appointment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.